Atractylodin Ameliorates Colitis via PPAR alpha Agonism
Atractylodin Ameliorates Colitis via PPARα Agonism
- 문서 유형
- 연구출판물 · 학술지 논문
- 등재
- SCIEScopus
- 저널 순위
- JCR Q1Scopus Q1
- 저널
- INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES24(1) · 2023
- 피인용
- Web of Science 25Scopus 25
- FWCI (Scopus)
- 1.84
- JCR IF
- JCR 2022 5.6
- ISSN
- 1661-6596
저자
- 허광범제1저자Pusan Natl Univ, Coll Pharm, Pusan 46241, South Korea
- 김유주Pusan Natl Univ, Coll Pharm, Pusan 46241, South Korea
- 김은라Pusan Natl Univ, Coll Pharm, Pusan 46241, South Korea
- 박소영Pusan Natl Univ, Coll Pharm, Pusan 46241, South Korea
- Rhee, Sang HoonOakland Univ, Dept Biol Sci, Rochester, MI 48309 USA
- 정지형Pusan Natl Univ, Res Inst Drug Dev, Pusan 46241, South Korea
- 임은옥교신저자Pusan Natl Univ, Res Inst Drug Dev, Pusan 46241, South Korea
초록
© 2023 by the authors.Atractylodin is a major compound in the rhizome of Atractylodes lancea, an oriental herbal medicine used for the treatment of gastrointestinal diseases, including dyspepsia, nausea, and diarrhea. Recent studies have shown that atractylodin exerts anti-inflammatory effects in various inflammatory diseases. Herein, we investigated the anti-colitis effects of atractylodin and its molecular targets. We determined the non-cytotoxic concentration of atractylodin (50 μM) using a cell proliferation assay in colonic epithelial cells. We found that pretreatment with atractylodin significantly inhibits tumor necrosis factor-α-induced phosphorylation of nuclear factor-κ-light-chain-enhancer of activated B in HCT116 cells. Through docking simulation analysis, luciferase assays, and in vitro binding assays, we found that atractylodin has an affinity for peroxisome proliferator-activated receptor alpha (PPARα). Daily administration of atractylodin (40 mg/kg) increased the survival rate of mice in a dextran sodium sulfate-induced colitis mouse model. Thus, atractylodin can be a good strategy for colitis therapy through inducing PPARα-dependent pathways.
키워드
Atractylodes lanceaatractylodininflammatory bowel diseasePPAR alphaINFLAMMATIONACTIVATIONMECHANISMSBINDING
식별자
- Scopus EID
- 2-s2.0-85145969837
- WoS UID
- 000909023700001



로그인
연구물 목록으로